Radioresistance of glioma stem cells: Intrinsic characteristic or property of the 'microenvironment-stem cell unit'?

Molecular Oncology

Volumn 5, Issue 4, 2011, Pages 374-386

  Mannino, Mariella ^a   Chalmers, Anthony J ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Glioblastoma; Glioma stem cell; Microenvironment; Radiation; Radioresistance

Indexed keywords

BETA INTERFERON; BEVACIZUMAB; CD133 ANTIGEN; COLLAGEN; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENTACTIN; HEPARAN SULFATE; LAMININ; NITRIC OXIDE; OSTEONECTIN; TENASCIN; THROMBOSPONDIN; VITRONECTIN;

CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL SELECTION; CLONOGENESIS; DNA DAMAGE; ENDOTHELIUM CELL; EXTERNAL BEAM RADIOTHERAPY; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOXIA; IN VITRO STUDY; LASER MICROSCOPY; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; TUMOR DIFFERENTIATION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

EID: 80052182327     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.05.001     Document Type: Review

References (83)

1. Ader I., et al. The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunit. Oncogene 2002, 21(42):6471-6479.
2. Al-Mayhani T.M.F., et al. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. Journal of Neuroscience Methods 2009, 176(2):192-199.
3. Bao S.D., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444(7120):756-760.
4. Bao S.D., et al. Stem cell-like glioma cells promote tumour angiogenesis through vascular endothelial growth factor. Cancer Research 2006, 66(16):7843-7848.
5. Beier D., et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research 2007, 67(9):4010-4015.
6. Bellail A.C., et al. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. International Journal of Biochemistry & Cell Biology 2004, 36(6):1046-1069.
7. Bokhari M., et al. Novel cell culture device enabling three-dimensional cell growth and improved cell function. Biochemical and Biophysical Research Communications 2007, 354(4):1095-1100.
8. Brown C.K., et al. Glioblastoma cells block radiation-induced programmed cell death of endothelial cells. Febs Letters 2004, 565(1-3):167-170.
9. Buckley A., et al. Sustained release of epidermal growth factor accelerates wound repair. Proceedings of the National Academy of Sciences of the United States of America 1985, 82(21):7340-7344.
10. Calabrese C., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11(1):69-82.
11. Campos B., Herold-Mende C.C. Insight into the complex regulation of CD133 in glioma. International Journal of Cancer 2011, 128(3):501-510. Feb 1.
12. Capper D., et al. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival. Neuropathology and Applied Neurobiology 2010, 36(3):183-197.
13. Chang C.J., et al. Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochemical and Biophysical Research Communications 2009, 380(2):236-242.
14. Charles N., et al. Perivascular nitric oxide activates Notch signaling and promotes stem-like character in PDGF-Induced glioma cells. Cell Stem Cell 2010, 6(2):141-152.
15. Christensen K., Schroder H.D., Kristensen B.W. CD133 identifies perivascular niches in grade II-IV astrocytomas. Journal of Neuro-Oncology 2008, 90(2):157-170.
16. Clement V., et al. Marker-independent identification of glioma-initiating cells. Nature Methods 2010, 7(3):224-228.
17. CohenJonathan E., et al. Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G(2) delay and a hyperphosphorylation of p34(CDC2) in HeLa cells. Cancer Research 1997, 57(7):1364-1370.
18. Cordes N., et al. Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines. British Journal of Cancer 2003, 89(11):2122-2132.
19. Cordes N., et al. Beta 1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 2006, 25(9):1378-1390.
20. Cordes N., van Beuningeni D. Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3 beta (GSK-3 beta) in vitro. British Journal of Cancer 2003, 88(9):1470-1479.
21. Dittmann K., et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. Journal of Biological Chemistry 2005, 280(35):31182-31189.
22. Folkins C., et al. Glioma tumor stem-like cells promote tumor angiogenesis and Vasculogenesis via vascular endothelial growth factor and Stromal-derived factor 1. Cancer Research 2009, 69(20):8216. (vol 69, pg 7243, 2009).
23. Folkman J., et al. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. American Journal of Pathology 1988, 130(2):393-400.
24. Fuks Z., et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Research 1994, 54(10):2582-2590.
25. Galli R., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Research 2004, 64(19):7011-7021.
26. Garcia-Barros M., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300(5622):1155-1159.
27. Gunther H.S., et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008, 27(20):2897-2909.
28. Hambardzumyan D., et al. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes & Development 2008, 22(4):436-448.
29. Hamer P., et al. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 2008, 27(14):2091-2096.
30. Hemmati H.D., et al. Cancerous stem cells can arise from pediatric brain tumors. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(25):15178-15183.
31. Higuchi M., et al. Expression of Tenascin in human gliomas - its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathologica 1993, 85(5):481-487.
32. Horsman M.R., Overgaard J. The oxygen effect and tumour microenvironment. Basic Clinical Radiobiology 2002, 158-168. Arnold. G. Steel (Ed.).
33. Hovinga K.E., et al. Inhibition of Notch signaling in glioblastoma targets cancer stem cells via an endothelial cell Intermediate. Stem Cells 2010, 28(6):1019-1029.
34. Ignatova T.N., et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39(3):193-206.
35. Iwata S., et al. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery 1999, 45(1):24-28.
36. Jamal M., et al. Microenvironmental regulation of glioblastoma radioresponse. Clinical Cancer Research 2010, 16(24):6049-6059.
37. Knizetova P., Darling J.L., Bartek J. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. Journal of Cellular and Molecular Medicine 2008, 12(1):111-125.
38. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(3):781-786.
39. Lee J., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9(5):391-403.
40. Leins A., et al. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 2003, 98(11):2430-2439.
41. Levenberg S., et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proceedings of the National Academy of Sciences of the United States of America 2003, 100(22):12741-12746.
42. Li Z., et al. Hypoxia-Inducible factors Regulate tumorigenic Capacity of glioma stem cells. Cancer Cell 2009, 15(6):501-513.
43. Lindahl U., Li J.P. Interactions between heparan sulfate and proteins - design and functional implications. International Review of Cell and Molecular Biology 2009, Vol. 276:105-159. Elsevier Academic Press Inc, San Diego.
44. Liu Q.H., et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Journal of Neuro-Oncology 2009, 94(1):1-19.
45. Lobrich M., et al. Gamma H2AX foci analysis for monitoring DNA double-strand break repair Strengths, limitations and optimization. Cell Cycle 2010, 9(4):662-669.
46. Loilome W., et al. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling. Journal of Neuro-Oncology 2009, 94(3):359-366.
47. Lomonaco S.L., et al. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. International Journal of Cancer 2009, 125(3):717-722.
48. Maxhimer J.B., et al. Radioprotection in normal tissue and Delayed tumor growth by Blockade of CD47 signaling. Science Translational Medicine 2009, 1(3).
49. McCord A.M., et al. CD133(+) glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clinical Cancer Research 2009, 15(16):5145-5153.
50. McGee M.C., et al. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. International Journal of Radiation Oncology • Biology • Physics 2010, 76(5):1537-1545.
51. Midwood K.S., Orend G. The role of tenascin-C in tissue injury and tumorigenesis. Journal of cell communication and signaling 2009, 3:287-310.
52. Monferran S., et al. Alpha v beta 3 and alpha v beta 5 integrins control glioma cell response to ionising radiation through ILK and RhoB. International Journal of Cancer 2008, 123(2):357-364.
53. Ogden A.T., et al. Identification of A2B5(+)CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 2008, 62(2):505-514.
54. Overgaard J. Hypoxic radiosensitization: adored and ignored. Journal of Clinical Oncology 2007, 25(26):4066-4074.
55. Pallini R., et al. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clinical Cancer Research 2008, 14(24):8205-8212.
56. Pollard S., et al. Brain cancer stem cells: a level playing field. Cell Stem Cell 2009, 5(5):468-469.
57. Pollard S.M., et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4(6):568-580.
58. Reardon D.A., et al. Phase II trial of murine I-131-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. Journal of Clinical Oncology 2002, 20(5):1389-1397.
59. Reardon D.A., et al. A pilot study: I-131-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost. Neuro-Oncology 2008, 10(2):182-189.
60. Reynolds B.A., Vescovi A.L. Brain cancer stem cells: think twice before going flat. Cell Stem Cell 2009, 5(5):466-467.
61. Ricci-Vitiani L., et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468(7325):824-828. (vol 468, pg 824, 2010).
62. Rich J.N., et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Research 2005, 65(10):4051-4058.
63. Riekki R., et al. Radiation therapy induces tenascin expression and angiogenesis in human skin. Acta Dermato-Venereologica 2001, 81(5):329-333.
64. Rolle K., et al. Promising human brain tumors therapy with interference RNA intervention (iRNAi). Cancer Biology & Therapy 2010, 9(5):396-406.
65. Ropolo M., et al. Comparative analysis of DNA repair in stem and Nonstem glioma cell cultures. Molecular Cancer Research 2009, 7(3):383-392.
66. Salmaggi A., et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006, 54(8):850-860.
67. Sandfort V., Koch U., Cordes N. Cell adhesion-mediated radioresistance revisited. International Journal of Radiation Biology 2007, 83(11-12):727-732.
68. Sato A., et al. Regulation of neural stem/progenitor cell maintenance by PI3K and mTOR. Neuroscience Letters 2010, 470(2):115-120.
69. Shaifer C.A., Huang J.H., Lin P.C. Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance. International Journal of Cancer 2010, 127(9):2063-2075.
70. Singh S.K., et al. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
71. Son M.J., et al. SSEA-1 Is an Enrichment Marker for tumor-initiating Cells in human glioblastoma. Cell Stem Cell 2009, 4(5):440-452.
72. Steel G.G. The case against apoptosis. Acta Oncologica 2001, 40(8):968-975.
73. Strojnik T., et al. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surgical Neurology 2007, 68(2):133-144.
74. Tai I.T., et al. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy. Journal of Clinical Investigation 2005, 115(6):1492-1502.
75. Tamura K., et al. Accumulation of CD 133-positive glioma cells after high-dose irradiation by gamma knife surgery plus external beam radiation clinical article. Journal of Neurosurgery 2010, 113(2):310-318.
76. Thonhoff J.R., et al. Compatibility of human fetal neural stem cells with hydrogel biomaterials in vitro. Brain Research 2008, 1187:42-51.
77. Vickerman V., et al. Design, fabrication and implementation of a novel multi-parameter control microfluidic platform for three-dimensional cell culture and real-time imaging. Lab on a Chip 2008, 8(9):1468-1477.
78. Wang J., et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. International Journal of Cancer 2008, 122(4):761-768.
79. Wang R., et al. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468(7325):829-833.
80. Wang J.L., et al. Notch promotes radioresistance of glioma stem cells. Stem Cells 2010, 28(1):17-28.
81. Yuan X.P., et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23(58):9392-9400.
82. Zeppernick F., et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clinical Cancer Research 2008, 14(1):123-129.
83. Zhang M.Y., et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. Journal of Experimental & Clinical Cancer Research 2008, 27:7.